I use zinc citrate. Do a dietary analysis before taking any copper. The top quartile of serum copper got smacked in the Paris Prospective Study. How much would put you in the top quartile? In this
review it's above 1.86 mg/day.
Data from the surveys on which these calculations were based were pooled so the shape of the distribution of 849 diets could be defined and to allow comparison of diets to the revised standard [1]. The figure reveals positive skewness, but only 3.2% of the diets exceed 3.0 mg/day; 61% are less than 1.5 mg/day and approximately one-third are less than 1 mg. The middle quartiles ranged from 0.91 to 1.86 mg/day. This distribution is representative of diets made from conventional foods in Belgium, Canada, UK and the US [7].
LEF's Only Trace Minerals and AOR's Zinc - Copper Balance are only for the suicidal. 136% of the UL for manganese in LEF's! And their 2 mg of copper puts you in the kill zone before you even add in what you get in food.
Epidemiology. 2006 May;17(3):308-14.
Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality.
Leone N, Courbon D, Ducimetiere P, Zureik M.
Unit 744 National Institute of Health and Medical Research (INSERM), Lille Pasteur Institute, Lille, France.
BACKGROUND: Experimental data suggest that zinc, copper, and magnesium are involved in carcinogenesis and atherogenesis. Few longitudinal studies have related these minerals to cancer or cardiovascular disease mortality in a population. METHODS: Data from the Paris Prospective Study 2, a cohort of 4035 men age 30-60 years at baseline, were used to assess the association between serum zinc, copper, and magnesium and all-cause, cancer, and cardiovascular disease mortality. Serum mineral values measured at baseline were divided into quartiles and classified into low (1st quartile, referent group), medium (2nd-3rd quartiles), and high (4th quartile) values. During 18-year follow up, 339 deaths occurred, 176 as a result of cancer and 56 of cardiovascular origin. Relative risks (RRs) for each element were inferred using Cox's proportional hazard model after controlling for various potential confounders. RESULTS: High copper values (4th quartile) were associated with a 50% increase in RRs for all-cause deaths (RR = 1.5; 95% confidence interval = 1.1-2.1), a 40% increase for cancer mortality (1.4; 0.9-2.2), and a 30% increase for cardiovascular mortality (1.3; 0.6-2.8) compared with low values (1st quartile). High magnesium values were negatively related to mortality with a 40% decrease in RR for all-cause (0.6; 0.4-0.8) and cardiovascular deaths (0.6; 0.2-1.2) and by 50% for cancer deaths (0.5; 0.3-0.8). Additionally, subjects with a combination of low zinc and high copper values had synergistically increased all-cause (2.6; 1.4-5.0) and cancer (2.7; 1.0-7.3) mortality risks. Similarly, combined low zinc and high magnesium values were associated with decreased all-cause (0.2; 0.1-0.5) and cancer (0.2; 0.1-0.8) mortality risks. CONCLUSIONS: High serum copper, low serum magnesium, and concomitance of low serum zinc with high serum copper or low serum magnesium contribute to an increased mortality risk in middle-aged men.
PMID: 16570028